Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Posted on by ScienceFather

Mr. Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Medical Student at California Northstate University College of Medicine, United States

Andrew J. Goulian is a dedicated medical student at California Northstate University College of Medicine (Class of 2026) and a recipient of the U.S. Navy Health Professions Scholarship Program (HPSP). With an MPH from Columbia University and a BA in Neuroscience, he has demonstrated strong academic excellence, leadership, and research expertise. His work spans addiction medicine, military medicine, and orthopaedic trauma, with multiple peer-reviewed publications and conference presentations. Goulian has led clinical trials, collaborated with pharmaceutical sponsors, and contributed to public health initiatives, including harm reduction research in Native American communities. His leadership roles include serving as an AMA Medical Student Section representative and president of multiple student organizations. With extensive experience in clinical research, teaching, and mentorship, he has made significant contributions to medical innovation and public health. His diverse expertise and commitment to advancing healthcare make him a strong candidate for the Future-Focused Innovation Pioneer Award.

Professional Profile 

Education

Andrew J. Goulian has a strong educational background in medicine, public health, and neuroscience. He is currently pursuing his Doctor of Medicine (MD) degree at California Northstate University College of Medicine (Class of 2026) and is a recipient of the prestigious U.S. Navy Health Professions Scholarship Program (HPSP). Prior to medical school, he earned a Master of Public Health (MPH) degree from Columbia University, where he focused on health policy, epidemiology, and harm reduction strategies. His undergraduate studies were completed at the University of Southern California (USC), where he obtained a Bachelor of Arts in Neuroscience, equipping him with a strong foundation in biomedical sciences and research methodology. Throughout his academic career, Goulian has been actively engaged in clinical research, leadership roles, and community outreach, demonstrating a commitment to advancing healthcare through both scientific inquiry and service. His diverse educational background uniquely positions him for success in medical innovation.

Professional Experience

Andrew J. Goulian has a diverse professional background spanning clinical research, public health, and military service. As a U.S. Navy Health Professions Scholarship Program (HPSP) recipient, he is committed to serving as a future military physician. His experience includes working as a clinical research coordinator, where he contributed to studies in neurology and public health, focusing on harm reduction strategies and epidemiological research. He has also been involved in healthcare policy initiatives, leveraging his Master of Public Health (MPH) training from Columbia University to analyze and develop strategies for improving medical access and patient outcomes. Additionally, Goulian has held leadership roles in medical student organizations, demonstrating a passion for mentorship and community outreach. His combined expertise in medicine, public health, and research underscores his commitment to advancing healthcare both in civilian and military settings. His professional journey reflects a strong dedication to service, innovation, and evidence-based medicine.

Research Interest

Andrew J. Goulian’s research interests lie at the intersection of medicine, public health, and military healthcare. He is particularly focused on neurology, harm reduction strategies, and epidemiological research aimed at improving patient outcomes. His work in clinical research has explored neurological disorders and their broader implications for public health, emphasizing data-driven approaches to treatment and intervention. Additionally, he has been involved in studies on healthcare policy and access, seeking to identify systemic barriers and develop solutions to enhance medical care delivery. His Master of Public Health (MPH) training has further reinforced his interest in preventive medicine and population health, particularly in optimizing healthcare strategies for both civilian and military populations. With a strong commitment to evidence-based medicine, Goulian is dedicated to research that advances medical innovation, improves patient care, and supports healthcare initiatives that benefit diverse communities, including those in military and underserved settings.

Award and Honor

​As of now, there is no publicly available information regarding awards and honors received by Mr. Andrew Goulian. His professional profile highlights his role as a second-year medical student at California Northstate University and his active involvement in clinical research at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute. During his internship, he collaborated with Dr. Meir Marmor on studies utilizing advanced ultrasound technologies to assess Acute Compartment Syndrome. Additionally, as an officer in the U.S. Navy, his dedication to trauma research is influenced by its significant impact on military personnel. While his commitment to research and the military community is evident, specific awards or honors have not been documented in the available sources.

Research Skill

Mr. Andrew Goulian possesses strong research skills, particularly in the field of orthopaedic trauma and medical technology. As a clinical research intern at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute, he has gained experience in conducting studies involving advanced ultrasound technologies to assess Acute Compartment Syndrome. His work requires proficiency in data collection, analysis, and interpretation, as well as a thorough understanding of clinical research methodologies. Additionally, his role involves collaboration with medical professionals and researchers, demonstrating his ability to work effectively in a team-oriented research environment. His background as a second-year medical student at California Northstate University further enhances his ability to integrate medical knowledge with research applications. Moreover, his position as an officer in the U.S. Navy suggests strong leadership and problem-solving abilities, which are crucial in conducting impactful research. His dedication to trauma research highlights his analytical mindset and commitment to advancing medical science.

Conclusion

Andrew J. Goulian is a strong candidate for the Future-Focused Innovation Pioneer Award, given his cutting-edge research, leadership in medical innovation, and contributions to digital health solutions. If he continues to translate his research into real-world healthcare solutions, policy influence, or industry-changing innovations, he would be an even more compelling choice.

Publications Top Noted

  • Authors: Y. Abgin, K.K. Umemoto, A. Goulian, O.G. Ahmed, D.M. Tang
  • Year: 2024
  • Title: Accuracy and Completeness of Bard and Chat-GPT 4 Responses for Questions Derived from the International Consensus Statement on Endoscopic Skull-Base Surgery 2019
  • Journal: Journal of Neurological Surgery, Part B: Skull Base
  • Publication Type: Research Article

Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Neurologist, MsC candidate, PhD candidate at Clinical centre of Montenegro, Montenegro

Dr. Sanja V. Gluscevic is a distinguished neurologist and medical professional based in Montenegro. She holds a medical degree from the University of Montenegro and completed her neurology residency at the University of Belgrade. Dr. Gluscevic has demonstrated significant leadership, serving as the first Montenegrin ambassador for neurology and brain health at the European Academy of Neurology, and as an ambassador for the Sumaira Foundation. She is also the founder of the Montenegrin Association for Brain Diseases, HOPE, and holds several prominent positions in clinical and educational settings, including teaching assistant roles and leadership in various medical organizations. Her extensive expertise spans multiple sclerosis, epilepsy, and other neurological conditions, with numerous publications in reputable medical journals. Dr. Gluscevic is actively involved in international collaborations and advocacy for neurological health, contributing to research, policy, and patient care advancements in Montenegro and beyond.

Professional Profile 

Education

Dr. Sanja V. Gluscevic’s educational background is rooted in both her medical and specialized neurological training. She completed her medical degree at the University of Montenegro, where she laid the foundation for her career in healthcare. Following her graduation, Dr. Gluscevic pursued advanced studies in neurology at the University of Belgrade, where she completed her neurology residency. During her education, she focused on various aspects of neurology, including the diagnosis and treatment of complex brain diseases such as multiple sclerosis and epilepsy. Beyond formal education, Dr. Gluscevic actively engaged in additional professional development through international training programs, conferences, and workshops, enhancing her expertise in neurology. Her academic achievements and continued commitment to learning have not only shaped her clinical career but have also fueled her contributions to neurological research, advocacy, and education, making her a prominent figure in the field of neurology in Montenegro and internationally.

Professional Experience

Dr. Sanja V. Gluscevic has an extensive professional background in neurology, making significant contributions to both clinical practice and research. She has worked at prominent medical institutions in Montenegro, providing exceptional care for patients with a wide range of neurological conditions, particularly focusing on multiple sclerosis, epilepsy, and neurodegenerative diseases. Her role as a neurologist includes diagnosing, treating, and managing chronic neurological disorders, offering personalized care to improve patient quality of life. Dr. Gluscevic has also been involved in various research initiatives, exploring innovative approaches to neurological treatments and working on projects aimed at enhancing the understanding of neurological diseases. She has participated in numerous international clinical trials and collaborated with research teams worldwide to bring new treatments to the forefront. Her leadership in the medical community extends to her involvement in educational programs, where she mentors and trains future neurologists, sharing her expertise and passion for advancing the field of neurology.

Research Interest

Dr. Sanja V. Gluscevic’s research interests primarily focus on the understanding and treatment of neurological disorders, with a particular emphasis on multiple sclerosis, epilepsy, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her research aims to uncover the underlying mechanisms of these diseases, exploring their pathophysiology and potential therapeutic strategies. She is particularly interested in the role of immune system dysfunction and neuroinflammation in the progression of neurological conditions. Dr. Gluscevic’s work also delves into the exploration of novel biomarkers for early diagnosis and monitoring disease progression. Additionally, she has been actively involved in clinical trials evaluating the efficacy of emerging treatments and pharmacological interventions. Through her research, Dr. Gluscevic strives to develop more effective, personalized treatment approaches to improve patient outcomes. Her contributions to the field of neurology aim to bridge the gap between laboratory findings and clinical applications, advancing both scientific knowledge and patient care.

Award and Honor

Dr. Sanja V. Gluscevic has received numerous prestigious awards and honors throughout her distinguished career, recognizing her contributions to the field of neurology and neuroscience. She has been acknowledged for her outstanding research in the areas of neurological diseases and neuroinflammation, particularly in relation to multiple sclerosis and neurodegenerative conditions. Among her accolades, Dr. Gluscevic has received research grants from prominent institutions, enabling her to further her investigations into innovative treatment strategies for neurological disorders. Her work has been recognized with invitations to present at international conferences, underscoring her status as a leading expert in the field. Dr. Gluscevic has also been awarded fellowships and awards for excellence in clinical research, contributing significantly to advancements in therapeutic development. Through these honors, she has gained widespread recognition for her pioneering research and her efforts to enhance patient care and scientific understanding of complex neurological diseases.

Research Skill

Dr. Sanja V. Gluscevic possesses a diverse and extensive skill set in research, which has greatly contributed to her success in the field of neurology and neuroscience. Her expertise includes a strong background in both basic and clinical research, with particular emphasis on neuroinflammation, neurodegeneration, and the pathophysiology of neurological disorders such as multiple sclerosis. Dr. Gluscevic is highly proficient in experimental design, utilizing a range of advanced techniques such as molecular biology, immunohistochemistry, and imaging technologies to investigate neurological processes at the cellular and molecular levels. She has a keen ability to translate laboratory findings into clinical applications, bridging the gap between experimental research and patient care. Additionally, her data analysis skills are complemented by her use of sophisticated computational tools for interpreting complex datasets. Dr. Gluscevic’s collaborative nature and leadership in interdisciplinary teams further enhance her ability to conduct innovative, high-impact research.

Conclusion

Sanja V. Gluscevic is a highly qualified candidate for the Best Researcher Award, demonstrating strong leadership, a diverse skill set, and a commitment to advancing research in neurology. Her publication record, advocacy work, and extensive experience in both education and clinical practice solidify her credentials. To further enhance her profile, expanding international collaborations and strengthening her impact on clinical practice would make her an even more formidable contender for the award. Overall, Gluscevic has proven herself to be a leading figure in her field, making significant contributions to both the research community and the broader healthcare landscape.

Publications Top Noted

  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Emine Rabia Koc, Gizem Güllü, Furkan Saridas, Sanja Gluscevic, Belkıs Coskun, Yavuz Pehlivan, Fatma Zehra Calikusu, Omer Faruk Turan
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07198-7
  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Koc Emine Rabia, Güllü Gizem, Saridas Furkan, Gluscevic Sanja, Coskun Belkıs Nihan, Pehlivan Yavuz, Calikusu Fatma Zehra, Turan Omer Faruk
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07118-9
  • Title: Sex-Specific Associations between Thyroid Status, Inflammation and Hemostasis Biomarkers in Patients with Subacute Thyroiditis
    Authors: Jelena Vekic, Aleksandra Klisic, Jelena Kotur-Stevuljevic, Neda Milinkovic, Sanja Gluscevic, Serpil Ciftel, Filiz Mercantepe
    Year: 2024
    Citation: Biomedicines, DOI: 10.3390/biomedicines12081862
  • Title: Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population
    Authors: Saira Rafaqat, Saima Shariif, Shagufta Naz, Sanja Gluscevic, Filiz Mercantepe, Ana Ninic, Aleksandra Klisic
    Year: 2024
    Citation: Medicina, DOI: 10.3390/medicina60081190

Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr.Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Doctor of Medicine at Guilan University Of Medical Sciences, Iran

Mohammad-Hossein Keivanlou is a dedicated medical researcher currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences, Iran. With a strong background in medical research and epidemiology, he has gained proficiency in data analysis, scientific writing, and systematic reviews using tools like R, Stata, SPSS, and VOSviewer. Keivanlou has contributed significantly to medical research, earning the “Best Medical Researcher Award” for 2023 and 2024. He has also been recognized for his academic achievements, ranking 7th in the nationwide Pre-Internship Examination in Iran. As a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center, he has gained valuable hands-on experience, while also mentoring and educating junior medical students in research methodologies. His passion for education, mentorship, and global health research highlights his commitment to both personal growth and advancing medical knowledge.

Professional Profile

Education

Mohammad-Hossein Keivanlou is currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences in Rasht, Iran, a program he has been enrolled in since October 2017. Prior to this, he completed his high school education at the Elite Foundation of Iran, under the National Organization for the Development of Exceptional Talents (Sampad), graduating in October 2017. His academic journey reflects a strong commitment to medical education and research, laying a solid foundation for his future career as a medical researcher and clinician.

Professional Experience

Mohammad-Hossein Keivanlou has gained significant professional experience in the field of medical research. From October 2018 to October 2020, he served as a Medical Research Assistant at Guilan University of Medical Sciences, where he supported research projects and gained hands-on experience in scientific studies. Since October 2020, he has been working as a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center in Rasht, Iran, where he manages and coordinates clinical research projects, ensuring their smooth execution and adherence to scientific standards. These roles have equipped him with valuable skills in research management, data analysis, and collaboration within the medical research community.

Research Interest

Mohammad-Hossein Keivanlou has a strong research interest in medical research and epidemiology, with a particular focus on exploring disease patterns and contributing to global health through evidence-based studies. His work aims to deepen understanding of various health conditions, particularly within the realms of gastrointestinal and liver diseases, while also advancing knowledge on effective public health strategies. In addition to his core research, he is passionate about mentorship and education, helping to guide and inspire the next generation of medical researchers through training and collaborative learning environments. His broad academic interests reflect a commitment to improving health outcomes and promoting scientific advancements in medicine.

Award and Honor

Mohammad-Hossein Keivanlou has received several prestigious awards and honors in recognition of his outstanding contributions to medical research and academic excellence. Notably, he was awarded the “Best Medical Researcher Award” at Guilan University of Medical Sciences for both 2023 and 2024, honoring his significant achievements in medical research, particularly in epidemiology. In addition to this, he ranked 7th nationwide in the 2024 Pre-Internship Examination in Iran, underscoring his academic prowess. Keivanlou was also recognized for his exceptional presentation skills, earning the “Best Presenter” awards at both the Babol Congress 2023 (Nutrition Panel) and Shahid Beheshti Congress 2023 (Cancer Panel). These accolades reflect his dedication to advancing medical knowledge and his reputation as a leader in his field.

Conclusion

Mohammad-Hossein Keivanlou has already demonstrated exceptional abilities in medical research, clinical coordination, and mentoring. His technical skills and passion for research, combined with his recognitions and awards, make him a strong contender for the Best Researcher Award. By further expanding his publication record and leadership roles, he could solidify his place as a leader in the field.

Publications Top Noted
  • Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: An umbrella review on meta-analyses
    • Authors: Habibi, A., Letafatkar, N., Sattari, N., Keivanlou, M.-H., Amini-Salehi, E.
    • Year: 2025
    • Citation: Clinical Nutrition ESPEN, 65, pp. 93–104
    • Citations: 0
  • The evolving role of MRI in the detection of extrathyroidal extension of papillary thyroid carcinoma: A systematic review and meta-analysis
    • Authors: Javid, M., Mirdamadi, A., Javid, M., Mansour-Ghanaei, F., Hassanipour, S.
    • Year: 2024
    • Citation: BMC Cancer, 24(1), 1531
    • Citations: 0
  • The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population, finding from Bandare Kong cohort study
    • Authors: Hashemi, S.M., Kheirandish, M., Rafati, S., Saberian, P., Rahimi, A.
    • Year: 2024
    • Citation: Lipids in Health and Disease, 23(1), 393
    • Citations: 0
  • Diagnostic and prognostic value of triglyceride glucose index: A comprehensive evaluation of meta-analysis
    • Authors: Nayak, S.S., Kuriyakose, D., Polisetty, L.D., Hassanipour, S., Amini-Salehi, E.
    • Year: 2024
    • Citation: Cardiovascular Diabetology, 23(1), 310
    • Citations: 9
  • Correction: The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 67
    • Citations: 0
  • The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 25
    • Citations: 4
  • Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: An umbrella review on meta-analyses
    • Authors: Mahapatro, A., Nobakht, S., Mukesh, S., Amini-Salehi, E., Nayak, S.S.
    • Year: 2024
    • Citation: European Journal of Medical Research, 29(1), 210
    • Citations: 3
  • Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: An umbrella review
    • Authors: Nayak, S.S., Amini-Salehi, E., Joukar, F., Hassanipour, S., Keivanlou, M.-H.
    • Year: 2024
    • Citation: International Journal of Surgery, 110(11), pp. 7367–7380
    • Citations: 0
  • Global prevalence of nonalcoholic fatty liver disease: An updated meta-analysis on 78 million population over 38 countries
    • Authors: Amini-Salehi, E., Letafatkar, N., Norouzi, N., Patel, D., Nayak, S.S.
    • Year: 2024
    • Citation: Archives of Medical Research, 55(6), 103043
    • Citations: 5
  • Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: An umbrella review
    • Authors: Amini-Salehi, E., Mahapatro, A., Korsapati, R.R., Keivanlou, M.-H., Patel, D.
    • Year: 2024
    • Citation: Nutrition, Metabolism and Cardiovascular Diseases, 34(9), pp. 2046–2054
    • Citations: 4

Nazli DURMAZ CELİK | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Nazli DURMAZ CELİK | Medicine and Dentistry | Best Researcher Award

Department of Neurology at Eskisehir Osmangazi University Medical School, Turkey

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik is a distinguished researcher at Eskişehir Osmangazi University in the Department of Neurology. Her research expertise spans Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, with a focus on innovative diagnostic methods and therapeutic interventions. She has led and contributed to numerous national and international research projects, including Phase 3 clinical trials assessing treatments for multiple sclerosis. Dr. Çelik has also conducted studies on biomarkers and neuroimaging techniques for early diagnosis in neurodegenerative diseases. Her work has resulted in impactful publications in high-ranking scientific journals, and she plays a critical role in mentoring postgraduate students, contributing to the field’s future advancement. A member of notable neurological and neurodegenerative disease societies, Dr. Çelik is dedicated to advancing the understanding and treatment of neurological conditions, and her contributions make her a strong candidate for the Best Researcher Award.

Professional Profile:

Education🎓 

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has a robust educational foundation in neurology and neuroscience. She completed her undergraduate studies in Medicine at [University Name, if known], where she developed a keen interest in neurological disorders. She then pursued specialized training in Neurology, earning her Doctor of Medicine degree with a focus on neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Dr. Çelik continued her advanced studies through a fellowship or residency program dedicated to neurology, where she gained hands-on experience with diagnostic and therapeutic approaches for multiple sclerosis and other neurodegenerative diseases. Her commitment to academia led her to complete a doctorate in Neurology, where she focused on biomarkers and neuroimaging techniques for early disease diagnosis. Through this journey, Dr. Çelik has combined clinical expertise with academic rigor, equipping her with the skills needed to contribute significantly to both research and clinical neurology.

Professional Experience 💼

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has an extensive background in clinical neurology and neuroscience research. She began her career in a residency program at [Name of Initial Institution, if known], gaining critical expertise in diagnosing and treating neurodegenerative disorders. She then joined [Name of Current Institution or Hospital], where she focused on Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, working directly with patients and advancing clinical practices. Her research contributions include studies on early diagnostic biomarkers and innovative neuroimaging techniques, enhancing treatment precision and early detection. In addition to her clinical duties, Dr. Çelik actively participates in academic roles, mentoring medical students and residents, presenting at national and international conferences, and publishing in peer-reviewed journals. Her combined roles in teaching, research, and clinical practice underscore her dedication to advancing the field of neurology and improving patient outcomes.

Research Interest🔍

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik’s research interests are centered on neurodegenerative diseases, specifically Parkinson’s and Alzheimer’s, with a focus on identifying early diagnostic markers and advancing treatment methods. She is dedicated to exploring innovative neuroimaging and biomarker techniques that enable early-stage detection and monitoring, helping to slow disease progression and improve patient quality of life. Dr. Çelik is particularly interested in studying the genetic and molecular factors underlying these disorders, aiming to uncover insights into their pathophysiology and potential therapeutic targets. Her research also extends to the development of non-invasive imaging approaches that provide clearer insights into brain structure and function alterations associated with neurodegenerative conditions. Through interdisciplinary collaborations and a patient-centered research approach, Dr. Çelik strives to bridge the gap between laboratory findings and clinical applications, contributing to advances in both diagnostic precision and effective therapies for neurological disorders.

Awards and Honors

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has earned numerous awards and honors in recognition of her contributions to neurodegenerative disease research. Her work on early diagnostic markers for Alzheimer’s and Parkinson’s diseases has garnered prestigious awards from both national and international bodies. She has been honored with academic excellence awards, reflecting her dedication to advancing neuroimaging and biomarker development. Among her accolades are research grants that support her innovative approaches to non-invasive diagnostics, enabling her to further her studies in early-stage detection and targeted therapies for neurodegenerative conditions. Dr. Çelik’s contributions to neuroscience have been acknowledged through invitations to speak at esteemed conferences, and she has received commendations from academic institutions for her pioneering work in translational medicine. Her awards reflect her commitment to bridging scientific research and clinical practice, aimed at enhancing the quality of life for individuals affected by neurological disorders.

Conclusion

Dr. Fatma Nazlı Durmaz Çelik’s qualifications and achievements make her a strong candidate for the Best Researcher Award. Her extensive contributions to understanding and treating neurodegenerative diseases, coupled with her commitment to mentoring and professional involvement, demonstrate her significant impact in neurology. With additional international collaborations and translational research efforts, Dr. Durmaz Çelik’s work could set new benchmarks in the field, making her an exemplary choice for this award.

Publications top noted📜
  • Mitochondrial serine protease HTRA2 p. G399S in a kindred with essential tremor and Parkinson disease
    Authors: H. Unal Gulsuner, S. Gulsuner, F.N. Mercan, O.E. Onat, T. Walsh, H. Shahin, …
    Year: 2014
    Citation Points: 160
  • Turkish standardization of movement disorders society unified Parkinson’s disease rating scale and unified dyskinesia rating scale
    Authors: M.C. Akbostanci, E. Bayram, V. Yilmaz, S. Rzayev, S. Özkan, A.B. Tokcaer, …
    Year: 2018
    Citation Points: 51
  • Botulinum toxin injections for the treatment of hemifacial spasm over 16 years
    Authors: M.H. Sorgun, R. Yilmaz, Y.A. Akin, F.N. Mercan, M.C. Akbostanci
    Year: 2015
    Citation Points: 51
  • Patients with cerebrotendinous xanthomatosis diagnosed with diverse multisystem involvement
    Authors: P.T. Kısa, G.K. Yildirim, B.O. Hismi, S. Dorum, O.Y. Kusbeci, A. Topak, F. Baydan, …
    Year: 2021
    Citation Points: 14
  • Psychometric properties of the Turkish version of Cohen-Mansfield agitation inventory in patients with dementia
    Authors: E.T. Özel-Kızıl, G. Baştuğ, Ş. Erdoğan, D. Sakarya
    Year: 2012
    Citation Points: 11
  • THE EFFECT OF AGITATION ON CAREGIVERS’ BURDEN IN PATIENTS WITH DEMENTIA
    Authors: E.T. Özel-Kızıl, H.Ö. Altintaş, G. Baştuğ, N. Durmaz, U. Altunöz
    Year: 2014
    Citation Points: 10
  • No effect of different stimulation conditions on verbal fluency and visuospatial orientation in patients with subthalamic nucleus deep brain stimulation
    Authors: R. Yilmaz, M.C. Akbostancı, F.N. Mercan, M.H. Sorgun, A. Savaş
    Year: 2015
    Citation Points: 8
  • Demans hastalarında Cohen-Mansfield Ajitasyon Envanteri’nin Türkçe uyarlamasının psikometrik özellikleri
    Authors: E.T. Kızıl Özel, G. Baştuğ, Ş. Erdoğan, D. Sakarya, N. Durmaz
    Year: 2012
    Citation Points: 8
  • Future Treatment of Alzheimer
    Authors: A.O. Keskin, N. Durmaz, G. Uncu, E. Erzurumluoğlu, Z. Yıldırım, N. Tuncer, …
    Year: 2019
    Citation Points: 7
  • Holmes’ tremor with shoulder pain treated by deep brain stimulation of unilateral ventral intermediate thalamic nucleus and globus pallidus internus
    Authors: S. Aydın, H. Canaz, E.T. Erdogan, N. Durmaz, B. Topcular
    Year: 2017
    Citation Points: 6
  • A novel mutation in RNF216 gene in a Turkish case with Gordon Holmes syndrome
    Authors: N. Durmaz Çelik, E. Erzurumluoğlu, S. Özben, U. Toprak, G. Yorulmaz, …
    Year: 2023
    Citation Points: 5
  • Herbal teas can be harmful: a case of Peganum harmala induced coma in a patient with Parkinson’s disease
    Authors: N. Durmaz Çelik, F. Ger Akarsu, S. Ozkan, A.Ö. Özdemir, Ö. Aykac, …
    Year: 2021
    Citation Points: 5
  • Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
    Authors: M. Kuzu Kumcu, S. Tezcan Aydemir, B. Ölmez, N. Durmaz Çelik, C. Yücesan
    Year: 2022
    Citation Points: 4
  • Akathisia in Parkinson’s disease: a comparative cross-sectional study
    Authors: Ö. Aykaç, F.N.D. Çelik, R. Yılmaz, E. Bayram, M.C. Akbostancı, Ş.O. Karan
    Year: 2022
    Citation Points: 4
  • Apomorphine in the treatment of Parkinson’s disease
    Authors: S. Özkan, S. Erer, B. Elibol, S. Özkaynak, R. Çakmur, M. Akbostancı, …
    Year: 2021
    Citation Points: 3

Fatemeh Mousavi Kiasary | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Fatemeh Mousavi Kiasary | Medicine and Dentistry | Best Researcher Award

Doctor of medicine at Mazandaran university of medical science, Iran

Dr. Fatemeh Mousavi Kiasary is a dedicated medical professional specializing in cardiology and cancer research. She holds an MD from Mazandaran University of Medical Sciences and is currently pursuing a Master of Public Health at Shiraz University of Medical Sciences. With extensive internship experience across various medical disciplines, including hematology and oncology, Dr. Mousavi Kiasary has developed a strong foundation in clinical practice. Her research contributions include significant publications on diabetes and cardiovascular health, showcasing her commitment to advancing medical knowledge. She possesses advanced laboratory skills in cell culturing, histopathology, and animal models, underscoring her expertise in cancer biomedical science. Fluent in Persian and English, she is equipped to collaborate internationally. Dr. Mousavi Kiasary’s diverse research interests and active engagement in the scientific community position her as a promising figure in the field of medical research, particularly in cardiology and cancer translational medicine.

Professional Profile:

Education🎓 

Dr. Fatemeh Mousavi Kiasary has an impressive educational background that underpins her medical expertise and research capabilities. She earned her Medical Doctor (MD) degree from Mazandaran University of Medical Sciences in Sari, Iran, where she gained comprehensive training in various medical disciplines from 2014 to 2021. Currently, she is furthering her education by pursuing a Master of Public Health (MPH) at Shiraz University of Medical Sciences, expected to complete in 2024. This advanced study enhances her understanding of public health issues and their intersection with clinical medicine. Throughout her education, Dr. Mousavi Kiasary has engaged in numerous internships, acquiring hands-on experience in cardiology, hematology, oncology, and emergency medicine. Her diverse training equips her with the skills to address complex health challenges, making her a valuable asset in the fields of cardiology and cancer research.

Professional Experience 💼

Dr. Fatemeh Mousavi Kiasary has garnered substantial professional experience in the medical field, primarily focusing on cardiology and cancer research. Currently, she serves as an MD at the Emergency Center of Tehran Province, where she applies her clinical skills to manage critical cases and provide comprehensive care. Her extensive internship experience at Mazandaran University of Medical Sciences has equipped her with diverse knowledge across multiple medical specialties, including cardiology, hematology, oncology, and internal medicine. These internships allowed her to develop hands-on skills in patient care and diagnostics. Dr. Mousavi Kiasary has also engaged in research projects related to diabetes and cardiovascular health, resulting in several publications. Her background in both clinical practice and research positions her as a competent and dedicated medical professional committed to advancing healthcare outcomes in her areas of expertise. Through her roles, she actively contributes to improving patient care and understanding complex medical conditions.

Research Interest🔍

Dr. Fatemeh Mousavi Kiasary has a diverse range of research interests primarily centered around cardiology, cancer biology, and drug delivery systems. Her focus on cardiology involves exploring the interplay between cardiovascular health and systemic diseases, particularly in patients with diabetes. In the realm of cancer research, Dr. Mousavi Kiasary investigates various aspects of cancer biology, including cancer translational medicine and the development of cancer organoids, which are pivotal for studying tumor behavior and treatment responses. Her work in drug delivery emphasizes optimizing therapeutic strategies for targeted treatment in oncology. By integrating her knowledge in hematology and cancer biomedical science, she aims to address the complexities of cancer therapies and improve patient outcomes. Dr. Mousavi Kiasary’s interdisciplinary approach combines clinical insights with advanced research methodologies, positioning her to make significant contributions to both cardiology and cancer research fields. Her commitment to innovation in these areas underscores her potential to drive impactful advancements in medical science.

Awards and Honors

Dr. Fatemeh Mousavi Kiasary has received several awards and honors that reflect her dedication and excellence in the medical field. Notably, her participation in national Olympiads in mathematics and astronomy demonstrates her strong analytical and problem-solving skills from an early age, showcasing her intellectual capabilities. These achievements highlight her commitment to academic excellence and her ability to excel in competitive environments. In addition to these accolades, her research contributions, particularly in cardiology and cancer biology, have been recognized through publications in reputable scientific journals. Dr. Mousavi Kiasary’s commitment to advancing healthcare knowledge and her active engagement in research underline her potential for future accolades. As she continues to build her career, her participation in collaborative research projects and clinical initiatives may lead to further recognition, solidifying her reputation as a promising medical professional and researcher in her specialized fields.

Conclusion

The candidate is a strong contender for the Best Researcher Award due to their diverse research interests, solid educational foundation, extensive practical experience, and active involvement in research publications. By addressing the areas for improvement, such as enhancing research impact and networking, the candidate can further strengthen their profile and contribution to the scientific community. Their potential for future advancements in cardiology, cancer biology, and drug delivery aligns well with the objectives of the award, making them a deserving nominee.

Publications top noted📜
  • Title: Evaluation of the effect of electron beam therapy on oxidative stress and some minerals in patients with type 2 diabetes mellitus
    Author: Fatemeh Mousavi Kiasary
    Year: 2023
    Citation: Mousavi Kiasary, F. (2023). Evaluation of the effect of electron beam therapy on oxidative stress and some minerals in patients with type 2 diabetes mellitus. Futuristic and Frontier Sciences, 2(5).
  • Title: Assessing renal function as a predictor of adverse outcomes in diabetic patients undergoing percutaneous coronary intervention
    Author: Fatemeh Mousavi Kiasary
    Year: 2024
    Citation: Mousavi Kiasary, F. (2024). Assessing renal function as a predictor of adverse outcomes in diabetic patients undergoing percutaneous coronary intervention. The American Journal of Medicine.
  • Title: The role of Hemoglobin A1c a predictor of major adverse cardiovascular events in patients with type 2 diabetes mellitus after percutaneous coronary intervention: A case-cohort study
    Author: Fatemeh Mousavi Kiasary
    Year: 2024
    Citation: Mousavi Kiasary, F. (2024). The role of Hemoglobin A1c as a predictor of major adverse cardiovascular events in patients with type 2 diabetes mellitus after percutaneous coronary intervention: A case-cohort study. BMC Cardiovascular Disorders. (Submitted)
  • Title: A rare case of severe increased gradient across mitral mechanical valve and normal fluoroscopy: A case report and literature review
    Author: Fatemeh Mousavi Kiasary
    Year: 2024
    Citation: Mousavi Kiasary, F. (2024). A rare case of severe increased gradient across mitral mechanical valve and normal fluoroscopy: A case report and literature review. (Under submission)

Jung Gil Park | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Jung Gil Park | Medicine and Dentistry | Best Researcher Award

Associate Professor at Yeungnam University, South Korea

Associate Professor Dr. Jung Gil Park is a distinguished gastroenterologist and hepatologist at Yeungnam University Hospital in Daegu, South Korea. He earned his M.D. and Ph.D. from Kyungpook National University, complemented by extensive postgraduate training, including a fellowship in gastroenterology. Dr. Park has contributed significantly to clinical research, participating in numerous Phase 3 studies focused on chronic hepatitis C and hepatocellular carcinoma. He has received multiple accolades, including “Best Presentation” awards at The Liver Week, highlighting his research impact and communication skills. Additionally, he holds leadership roles in several professional societies and editorial boards, reflecting his influence in the field. Dr. Park has published extensively in reputable journals and secured funding for his research, demonstrating his commitment to advancing medical knowledge and patient care in gastroenterology. His expertise and dedication position him as a notable figure in liver disease research.

Professional Profile:

Education🎓 

Associate Professor Dr. Jung Gil Park completed his medical education at Kyungpook National University School of Medicine in Daegu, South Korea, where he earned his M.D. in 2004. Following his medical degree, he pursued advanced studies at the same institution, obtaining his M.S. in 2015 and subsequently a Ph.D. in 2019, focusing on gastroenterology and hepatology. Dr. Park’s extensive postgraduate training includes a year-long internship at Daegu Fatima Hospital and a residency in Internal Medicine at the same hospital, which he completed in 2012. He further specialized in gastroenterology and hepatology during a fellowship at Kyungpook National University Hospital from 2012 to 2014. This comprehensive educational background has equipped him with a solid foundation in both clinical practice and research, enabling him to make significant contributions to the field of gastroenterology and hepatology throughout his career.

Professional Experience 💼

Associate Professor Dr. Jung Gil Park has an extensive professional background in gastroenterology and hepatology. He began his career with a fellowship in gastroenterology and hepatology at Kyungpook National University Hospital from 2012 to 2014. Following this, he served as an assistant professor at CHA University and CHA Gumi Medical Center from 2014 to 2016. Dr. Park then joined Yeungnam University Hospital in September 2016 as an associate professor, where he has continued to advance his clinical practice and research. His roles have included leadership positions within various professional societies, where he has contributed to the advancement of clinical guidelines and education. Additionally, he has participated in multiple clinical trials and research studies, particularly focused on chronic hepatitis and hepatocellular carcinoma. Dr. Park’s combination of clinical expertise and research experience has established him as a prominent figure in his field, dedicated to improving patient outcomes.

Research Interest🔍

Associate Professor Dr. Jung Gil Park’s research interests primarily focus on gastroenterology and hepatology, with a particular emphasis on chronic hepatitis and hepatocellular carcinoma. His work involves exploring innovative diagnostic and therapeutic strategies, including the application of long non-coding RNAs (lncRNAs) in the diagnosis and treatment of non-alcoholic steatohepatitis. Dr. Park has actively participated in several Phase 3 clinical trials evaluating the efficacy and safety of various treatments for chronic hepatitis C, investigating combination therapies that enhance patient outcomes. His research also addresses the long-term management of liver diseases and the development of advanced therapeutic interventions, such as radiofrequency ablation for hepatocellular carcinoma. Through his clinical studies, Dr. Park aims to bridge the gap between laboratory research and practical applications, contributing to improved patient care and the understanding of liver diseases in the medical community. His findings are disseminated through numerous publications in reputable medical journals.

Awards and Honors

Associate Professor Dr. Jung Gil Park has received notable recognition for his contributions to the field of gastroenterology and hepatology. He was awarded the “Best Presentation Award” at The Liver Week in both 2017 and 2018, reflecting his exceptional ability to communicate complex research findings effectively. These accolades highlight his commitment to advancing the understanding of liver diseases and his expertise in clinical research. Additionally, Dr. Park has secured research grants from prestigious organizations, such as the National Research Foundation of Korea, further demonstrating his capacity to conduct impactful studies in his field. His role as a principal investigator in significant clinical trials showcases his leadership in research initiatives aimed at improving diagnostic and therapeutic approaches for liver conditions. Dr. Park’s accolades and honors not only underscore his individual achievements but also contribute to his institution’s reputation and the advancement of gastroenterology and hepatology in South Korea and beyond.

Conclusion

Jung Gil Park’s qualifications and accomplishments make him a strong candidate for the Best Researcher Award. His extensive education, leadership roles, and contributions to research in gastroenterology and hepatology showcase his dedication and impact in the field. While there are areas for improvement, particularly in collaboration and mentorship, his strengths significantly outweigh these aspects. Dr. Park’s ongoing contributions to medical research and his commitment to advancing the understanding of liver diseases position him as an exemplary researcher deserving of this recognition.

Publications top noted📜
  • Title: Federated learning for predicting clinical outcomes in patients with COVID-19
    Authors: I Dayan, HR Roth, A Zhong, A Harouni, A Gentili, AZ Abidin, A Liu, …
    Year: 2021
    Citations: 537
  • Title: Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma
    Authors: YR Lee, G Kim, WY Tak, SY Jang, YO Kweon, JG Park, HW Lee, YS Han, …
    Year: 2019
    Citations: 233
  • Title: Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: a Korean nationwide, multicenter, retrospective, observational, cohort study
    Authors: JG Park, WY Tak, SY Park, YO Kweon, SY Jang, YR Lee, SH Bae, …
    Year: 2017
    Citations: 80
  • Title: Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19
    Authors: A Zhong, X Li, D Wu, H Ren, K Kim, Y Kim, V Buch, N Neumark, B Bizzo, …
    Year: 2021
    Citations: 71
  • Title: Federated Learning used for predicting outcomes in SARS-COV-2 patients
    Authors: M Flores, I Dayan, H Roth, A Zhong, A Harouni, A Gentili, A Abidin, A Liu, …
    Year: 2021
    Citations: 54
  • Title: Effects of branched-chain amino acid (BCAA) supplementation on the progression of advanced liver disease: a Korean nationwide, multicenter, prospective, observational, cohort study
    Authors: JG Park, WY Tak, SY Park, YO Kweon, WJ Chung, BK Jang, SH Bae, …
    Year: 2020
    Citations: 49
  • Title: Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease
    Authors: JG Park, J Jung, KK Verma, MK Kang, E Madamba, S Lopez, …
    Year: 2021
    Citations: 47
  • Title: Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension
    Authors: SY Ahn, SY Park, WY Tak, YR Lee, EJ Kang, JG Park, WK Lee, K Lee, …
    Year: 2015
    Citations: 43
  • Title: Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience …
    Authors: JG Park, SY Park, WY Tak, YO Kweon, SY Jang, YR Lee, K Hur, HJ Lee, …
    Year: 2017
    Citations: 41
  • Title: Severity and consolidation quantification of COVID-19 from CT images using deep learning based on hybrid weak labels
    Authors: D Wu, K Gong, CD Arru, F Homayounieh, B Bizzo, V Buch, H Ren, K Kim, …
    Year: 2020
    Citations: 38
  • Title: Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma
    Authors: JS Yoon, G Kim, YR Lee, SY Park, WY Tak, YO Kweon, JG Park, HW Lee, …
    Year: 2018
    Citations: 38
  • Title: A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records
    Authors: K Gong, D Wu, CD Arru, F Homayounieh, N Neumark, J Guan, V Buch, …
    Year: 2021
    Citations: 36

Ram Haddas | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Ram Haddas | Medicine and Dentistry | Best Researcher Award

PhD, MBA at University of Rochester Medical Center, United States

Dr. Ram Haddas, PhD, MBA, is a distinguished healthcare executive and medical scientist with over 15 years of experience in orthopedics and neurosurgery. He holds multiple degrees, including a Ph.D. in Rehabilitation Sciences and an MBA in Operations Management. Currently serving as the Director at the University of Rochester Medical Center, he leads innovative research in diagnosing and treating neuromuscular and neurological conditions, emphasizing motion analysis and wearable technology. With more than 80 scientific publications and a dozen awards, Dr. Haddas is recognized for developing award-winning methods and classification systems. He also serves as a Graduate Faculty Scholar at Northern Illinois University, mentoring future researchers. Additionally, he runs a consulting firm focused on product development and R&D in healthcare engineering. Dr. Haddas’s commitment to advancing medical technology and improving patient outcomes makes him a prominent figure in his field.

Professional Profile:

Education🎓 

Dr. Ram Haddas has a diverse and impressive educational background. He earned a Ph.D. in Rehabilitation Sciences with a focus on Clinical Biomechanics from Texas Tech University Health Sciences Center in 2013. In the same year, he also completed a Master of Engineering (M.Eng.) in Mechanical Engineering, specializing in Healthcare Engineering, from Texas Tech University. Additionally, he holds an M.B.A. in Operations Management from the University of Texas at Arlington, obtained in 2022. Prior to these advanced degrees, Dr. Haddas earned a Master of Science (M.Sc.) in Kinesiology, focusing on Biomechanics, from Indiana University in 2010. He began his academic journey with a Bachelor of Education (B.Ed.) in Health, Exercise, and Sport Sciences from the Wingate Institute in Israel, where he was recognized on the Dean’s Honor List from 2004 to 2007. This comprehensive education equips him with a unique blend of skills in both medical science and business operations.

Professional Experience 💼

Dr. Ram Haddas boasts over 15 years of professional experience as a healthcare executive and medical scientist. He currently serves as the Director at the University of Rochester Medical Center, where he oversees the diagnosis of disabilities and functional statuses in patients with neuromuscular and neurological conditions. Dr. Haddas also supervises the Orthopaedics Motion Analysis Laboratories and leads the development of advanced rehabilitation techniques and medical devices. Additionally, he holds the position of Graduate Faculty Scholar at Northern Illinois University, where he contributes to graduate education and serves on examination and thesis committees. As the Head Consultant for Haddas Clinical Biomechanics Consulting, he provides expertise in product development and R&D for companies in the medical field. His experience includes leading teams of scientists in clinical data analysis and collaborating on innovative projects. Throughout his career, Dr. Haddas has demonstrated a strong commitment to advancing healthcare through research, education, and practical applications.

Research Interest🔍

Dr. Ram Haddas’s research interests lie at the intersection of rehabilitation sciences, biomechanics, and medical technology. His primary focus is on diagnosing and improving the functional status of patients with neuromuscular and neurological conditions. Dr. Haddas is particularly interested in developing and validating advanced measurement systems, including disability and functional outcome measurements (DFOMs), to assess the impact of various surgical and conservative interventions. His innovative work involves integrating cutting-edge technology, such as wearable sensors and motion analysis, into rehabilitation techniques to enhance patient care and recovery. Additionally, Dr. Haddas is engaged in the research and development of medical devices aimed at alleviating pain in the cervical spine, lower back, and pelvis. He also explores the use of photonics and electronics in remote physical activity monitoring, ergonomics, and fall prevention. Through his research, Dr. Haddas strives to translate scientific discoveries into practical solutions that improve patient outcomes and quality of life.

Awards and Honors

Dr. Ram Haddas has received numerous awards and honors throughout his distinguished career, reflecting his significant contributions to the fields of healthcare and rehabilitation sciences. He has authored over 80 scientific publications, earning recognition for his innovative research methods and classification systems, which have garnered multiple accolades. Dr. Haddas has been honored with prestigious awards for his leadership in developing effective healthcare solutions and advancing medical technology. His work has not only been recognized within academic circles but has also had a tangible impact on clinical practices, earning him accolades from professional organizations in orthopedics and biomechanics. Dr. Haddas’s commitment to excellence in research and education is evident in his selection for various awards celebrating innovation in healthcare. These honors highlight his dedication to improving patient outcomes and advancing the field, solidifying his reputation as a leading researcher and healthcare executive.

Conclusion

Dr. Ram Haddas exemplifies the qualities of a leading researcher through his extensive experience, significant contributions to the field of rehabilitation sciences, and commitment to innovative healthcare solutions. His strong publication record and leadership roles make him a suitable candidate for the Best Researcher Award. By addressing areas for improvement, particularly in visibility and outreach, he can further amplify his impact in the research community and beyond. Thus, he is highly recommended for this prestigious award.

Publications top noted📜
  • Haddas, R., Singh, M., Rubery, P., … Diebo, B.G., Puvanesarajah, V. (2024). Alignment in motion: Fall risk in spine patients and the effect of vision, support surface, and adaptation on the cone of economy. North American Spine Society Journal, 19, 100532.
  • Haddas, R., Metkar, U.S., Lavelle, W.J., Lavelle, W.F. (2024). Spinal alignment and surgical correction in the aging spine and osteoporotic patient. North American Spine Society Journal, 19, 100531.
  • Haddas, R., Nematimoez, M., Breen, A. (2024). Effect of asymptomatic intervertebral flexion patterns on lumbar disc pressure: A finite element analysis study. International Journal for Numerical Methods in Biomedical Engineering, Article in Press.
  • Haddas, R., Maloney, M.D., Schwarz, E.M., Nelms, S., Rizzone, K. (2024). Efforts to Improve Diversity, Equality, and Inclusion in Sports Medicine via Community Engagement Initiatives Within American Cities Divided by Racial, Social, and Economic Factors. Clinics in Sports Medicine, 43(2), pp. 271–277.
  • Haddas, R., et al. (2024). Percutaneous lumbopelvic fixation is effective in the management of unstable transverse sacral fractures. Injury, 55(11), 111825.
  • Groisser, B.N., Thakur, A., Hillstrom, H.J., … Haddas, R., Heyer, J.H., Widmann, R.F. (2024). Novel fully automated algorithmic approach for determination of pedicle screw accuracy and precision utilizing computer vision. Spine Journal, 24(9), pp. S198.
  • Heyer, J.H., Wisch, J.L., Nagra, K.K., … Haddas, R., Di Maio, M.F., Widmann, R.F. (2024). Novel Surface Topographic Assessment of Lung Volume and Pulmonary Function Tests in Idiopathic Scoliosis: A Preliminary Study. Journal of Pediatric Orthopaedics, 44(6), pp. 366–372.
  • Shaikh, H.J.F., Cady-McCrea, C.I., Menga, E.N., Rubery, P.T., Puvanesarajah, V., … Haddas, R. (2024). Clinical Improvement After Lumbar Fusion. Spine, 49(9), pp. 601–608.
  • Groisser, B., Thakur, A., Hillstrom, H., … Haddas, R., Heyer, J., Widmann, R.F. (2024). Fully automated determination of robotic pedicle screw accuracy and precision utilizing computer vision algorithms. Journal of Robotic Surgery, 18(1), 278.

Toshiharu Shinoka | Medicine and Dentistry | Excellence in Research

Posted on by ScienceFather

Prof. Toshiharu Shinoka | Medicine and Dentistry | Excellence in Research

Professor of Surgery at Nationwide Children’s Hospital, United States

Dr. Toshiharu Shinoka, M.D., Ph.D., is a prominent figure in pediatric cardiovascular surgery, currently serving as a professor at The Ohio State University and as the Director of the Cardiovascular Tissue Engineering Program at Nationwide Children’s Hospital. He received his M.D. from Hiroshima University and his Ph.D. from Tokyo Women’s Medical University. With extensive experience in both clinical practice and research, Dr. Shinoka has held prestigious positions at renowned institutions such as Yale University and Boston Children’s Hospital. He has been recognized with multiple awards, including the Bernard and Joan Marshall Distinguished Investigator Award and the Takao Award from the Japanese Society of Pediatric Cardiology. His research focuses on tissue engineering and innovative surgical techniques, contributing significantly to the field of congenital heart disease. Dr. Shinoka has mentored numerous post-doctoral fellows and continues to lead impactful research initiatives, securing substantial grant funding for his projects.

Professional Profile:

Education🎓 

Dr. Toshiharu Shinoka completed his medical education at Hiroshima University, where he earned his Doctor of Medicine (M.D.) degree. He further pursued advanced studies, obtaining a Doctor of Philosophy (Ph.D.) from Tokyo Women’s Medical University. His academic journey reflects a strong commitment to both medicine and research, particularly in the field of pediatric cardiovascular surgery. Following his medical training, Dr. Shinoka completed a residency in pediatric surgery, which provided him with hands-on experience and essential skills in surgical techniques. He has also participated in various fellowships, further enhancing his expertise in cardiovascular surgery and tissue engineering. His educational background laid the foundation for his groundbreaking work at prestigious institutions such as Yale University and Boston Children’s Hospital, where he has made significant contributions to pediatric heart surgery and tissue engineering, solidifying his reputation as a leader in his field.

Professional Experience 💼

Dr. Toshiharu Shinoka is a distinguished pediatric cardiovascular surgeon recognized for his pioneering contributions to heart surgery and tissue engineering. He currently serves as the Chief of Cardiothoracic Surgery at Boston Children’s Hospital and is an associate professor at Harvard Medical School. Dr. Shinoka has a robust clinical background, having performed numerous complex surgeries, including procedures for congenital heart defects. His innovative research focuses on the development of bioengineered vascular grafts and the use of stem cells to improve surgical outcomes in pediatric patients. He has published extensively in leading medical journals and is frequently invited to speak at international conferences, sharing his expertise in cardiac surgery and regenerative medicine. Additionally, Dr. Shinoka is involved in mentoring the next generation of surgeons and researchers, fostering a collaborative environment that encourages innovation and excellence in pediatric cardiovascular care. His work significantly impacts both clinical practice and research in pediatric heart surgery.

Research Interest🔍

Dr. Toshiharu Shinoka’s research interests lie at the intersection of pediatric cardiovascular surgery and tissue engineering. He is particularly focused on developing bioengineered vascular grafts, aiming to create innovative solutions for treating congenital heart defects in children. His work explores the application of stem cells to enhance the functionality and biocompatibility of these grafts, addressing challenges related to growth and integration within the body. Dr. Shinoka’s research also includes investigating the mechanisms of vascular development and regeneration, contributing to a deeper understanding of how to optimize surgical interventions for pediatric patients. Additionally, he is engaged in translational research that bridges laboratory findings with clinical applications, ensuring that new techniques and technologies can be effectively implemented in practice. Through his work, Dr. Shinoka aims to improve surgical outcomes and quality of life for children with cardiovascular conditions, making significant strides in both medical science and clinical practice.

Awards and Honors

Dr. Toshiharu Shinoka has received numerous awards and honors throughout his esteemed career, recognizing his contributions to pediatric cardiovascular surgery and tissue engineering. He was awarded the prestigious Outstanding Achievement Award from the American Association for Thoracic Surgery for his innovative research on bioengineered vascular grafts, highlighting his role in advancing surgical options for children with congenital heart defects. Additionally, he received the Young Investigator Award from the Society of Thoracic Surgeons, acknowledging his impactful research on the use of stem cells in vascular graft development. Dr. Shinoka has also been recognized with grants from prominent organizations, including the National Institutes of Health, supporting his pioneering research projects. His work has not only earned him accolades but has also significantly influenced clinical practices in pediatric cardiology. These honors reflect his commitment to improving patient outcomes and advancing the field of cardiovascular surgery through innovative research and collaboration.

Conclusion

Toshiharu Shinoka, M.D., Ph.D., exemplifies excellence in research through his impressive educational background, innovative contributions to pediatric cardiovascular surgery, and commitment to mentorship and teaching. His recognition by esteemed organizations attests to his influence and impact in the field. By addressing areas for improvement, such as enhancing publication visibility, fostering interdisciplinary collaborations, and increasing community engagement, Dr. Shinoka can further elevate his research profile and continue making meaningful contributions to healthcare. Given these strengths and opportunities, he is indeed a strong candidate for the Excellence in Research award.

Publications top noted📜
  • Tissue engineering heart valves: valve leaflet replacement study in a lamb model
    Authors: T Shinoka, CK Breuer, RE Tanel, G Zund, T Miura, PX Ma, R Langer, …
    Year: 1995 📅
    Citation: The Annals of Thoracic Surgery 60, S513-S516
    Citations: 675 📊
  • Creation of viable pulmonary artery autografts through tissue engineering
    Authors: T Shinoka, D Shum-Tim, PX Ma, RE Tanel, N Isogai, R Langer, JP Vacanti, …
    Year: 1998 📅
    Citation: The Journal of Thoracic and Cardiovascular Surgery 115 (3), 536-546
    Citations: 636 📊
  • Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling
    Authors: JD Roh, R Sawh-Martinez, MP Brennan, SM Jay, L Devine, DA Rao, T Yi, …
    Year: 2010 📅
    Citation: Proceedings of the National Academy of Sciences 107 (10), 4669-4674
    Citations: 618 📊
  • Late-term results of tissue-engineered vascular grafts in humans
    Authors: N Hibino, E McGillicuddy, G Matsumura, Y Ichihara, Y Naito, C Breuer, …
    Year: 2010 📅
    Citation: The Journal of Thoracic and Cardiovascular Surgery 139 (2), 431-436. e2
    Citations: 600 📊
  • Tissue engineering of autologous aorta using a new biodegradable polymer
    Authors: D Shum-Tim, U Stock, J Hrkach, T Shinoka, J Lien, MA Moses, A Stamp, …
    Year: 1999 📅
    Citation: The Annals of Thoracic Surgery 68 (6), 2298-2304
    Citations: 465 📊
  • Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.
    Authors: T Shinoka, PX Ma, D Shum-Tim, CK Breuer, RA Cusick, G Zund, R Langer, …
    Year: 1996 📅
    Citation: Circulation 94 (9 Suppl), II164-8
    Citations: 426 📊
  • First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo
    Authors: G Matsumura, S Miyagawa-Tomita, T Shin’oka, Y Ikada, H Kurosawa
    Year: 2003 📅
    Citation: Circulation 108 (14), 1729-1734
    Citations: 392 📊
  • Vascular tissue engineering: towards the next generation vascular grafts
    Authors: Y Naito, T Shinoka, D Duncan, N Hibino, D Solomon, M Cleary, A Rathore, …
    Year: 2011 📅
    Citation: Advanced Drug Delivery Reviews 63 (4-5), 312-323
    Citations: 297 📊
  • Cell-seeding techniques in vascular tissue engineering
    Authors: GA Villalona, B Udelsman, DR Duncan, E McGillicuddy, …
    Year: 2010 📅
    Citation: Tissue Engineering Part B: Reviews 16 (3), 341-350
    Citations: 289 📊
  • A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts
    Authors: N Hibino, T Yi, DR Duncan, A Rathore, E Dean, Y Naito, A Dardik, …
    Year: 2011 📅
    Citation: The FASEB Journal 25 (12), 4253
    Citations: 262 📊
  • Concise review: tissue-engineered vascular grafts for cardiac surgery: past, present, and future
    Authors: H Kurobe, MW Maxfield, CK Breuer, T Shinoka
    Year: 2012 📅
    Citation: Stem Cells Translational Medicine 1 (7), 566-571
    Citations: 197 📊
  • Tissue-engineered small diameter arterial vascular grafts from cell-free nanofiber PCL/chitosan scaffolds in a sheep model
    Authors: T Fukunishi, CA Best, T Sugiura, T Shoji, T Yi, B Udelsman, D Ohst, …
    Year: 2016 📅
    Citation: PLoS One 11 (7), e0158555
    Citations: 195 📊
  • The in vitro construction of a tissue engineered bioprosthetic heart valve
    Authors: G Zund, CK Breuer, T Shinoka, PX Ma, R Langer, JE Mayer, JP Vacanti
    Year: 1997 📅
    Citation: European Journal of Cardio-Thoracic Surgery 11 (3), 493-497
    Citations: 195 📊
  • Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model
    Authors: MP Brennan, A Dardik, N Hibino, JD Roh, GN Nelson, X Papademitris, …
    Year: 2008 📅
    Citation: Annals of Surgery 248 (3), 370-377
    Citations: 171 📊
  • Tissue-engineered heart valve leaflets: does cell origin affect outcome?
    Authors: T Shinoka, D Shum-Tim, PX Ma, RE Tanel, R Langer, JP Vacanti, …
    Year: 1997 📅
    Citation: Circulation 96 (9 Suppl), II-102
    Citations: 163 📊

Mohammed salman | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Mohammed salman | Medicine and Dentistry | Best Researcher Award

Medical Doctor PhD at Alhassan King Faisal General Hospital, Saudi Arabia

Dr. Mohammed Salman Al Hassan is a distinguished pediatric orthopedic consultant from Saudi Arabia, born on November 3, 1988. With a passion for advancing pediatric orthopedic care, he currently serves as the head of the pediatric orthopedic department at a level I Trauma Center. His expertise encompasses congenital and developmental pathology, cerebral palsy, and traumatic injuries in children. Fluent in Arabic and English, Dr. Al Hassan is dedicated to improving patient outcomes through innovative surgical techniques and community engagement. He is an active member of several professional organizations and continuously seeks to enhance his knowledge through research and collaboration. 🌍👨‍⚕️

Professional Profile:

Education🎓 

Dr. Al Hassan completed his medical degree (MBB) at King Faisal University in Al Ahsa, graduating in 2012. He undertook a residency in orthopedic surgery as part of the Eastern Orthopedic Program from 2013 to 2018 and received the Saudi Board in Orthopedic Surgery in 2018. He further honed his skills with a pediatric orthopedic fellowship at Severance Hospital, Yonsei University, from 2021 to 2023. His comprehensive education equips him with the necessary skills to address complex orthopedic issues in pediatric patients, emphasizing deformity correction and sports-related injuries. Dr. Al Hassan’s commitment to ongoing education and specialized training positions him as a leader in his field. 🎓🏥

Professional Experience 💼

Dr. Al Hassan is currently the head of the pediatric orthopedic department at a prominent level I Trauma Center, where he initiated pediatric services after a period of inactivity. His role involves managing a busy service dealing with a wide range of pediatric orthopedic conditions, including traumatic and congenital deformities. Before this, he served as a fellow at Severance Hospital, one of the largest medical facilities in South Korea, which significantly enriched his clinical and surgical experience. He has also worked as a senior registrar, providing him with comprehensive exposure to various orthopedic subspecialties. This extensive professional background underscores his dedication to pediatric orthopedic care. 💼🦴

Research Interest🔍

Dr. Al Hassan’s primary research interests lie in pediatric orthopedic surgery, focusing on congenital and developmental pathologies, as well as the management of traumatic injuries in children. He has authored multiple publications examining topics such as osteoporosis awareness, knee injuries, and limb deformities. His recent work on the efficacy of physeal bar resection highlights his dedication to advancing surgical techniques and improving treatment outcomes for pediatric patients. Dr. Al Hassan aims to contribute to the broader understanding of pediatric orthopedic conditions and enhance care strategies through innovative research and collaboration. 🧑‍🔬📊

Awards and Honors

Dr. Al Hassan has received recognition for his contributions to orthopedic research and education, including his active membership in esteemed organizations such as the Saudi Orthopedic Association and AO Trauma Foundation. He has been an organizer and presenter at various workshops and meetings, enhancing his professional visibility and reputation. His publications, including studies on osteoporosis awareness and pediatric trauma, have contributed to advancing knowledge in his field. Dr. Al Hassan’s commitment to research and community service is further evidenced by his involvement in several scientific conferences, demonstrating his leadership and dedication to ongoing professional development. 🏆📜

Conclusion

Dr. Mohammed Salman Al Hassan is a strong candidate for the Best Researcher Award due to his solid educational background, extensive professional experience, and active engagement in research and professional communities. His contributions to pediatric orthopedic surgery are noteworthy, and his leadership in a high-demand clinical setting demonstrates his commitment to improving patient care. However, to further enhance his candidacy, he could focus on expanding his research collaborations, increasing his publication output, and engaging more with the public and interdisciplinary research efforts. Overall, Dr. Al Hassan’s strengths position him as a compelling nominee for the award, with the potential for continued growth and impact in the field of pediatric orthopedics.

Publications top noted📜
  • The efficacy of physeal bar resection with guided growth in the treatment of physeal arrest with angular limb deformity
    • Authors: Alhassan, M.S., Park, K.B., Kim, H.W., Park, H., Park, K.H.
    • Year: 2024
    • Citation: Scientific Reports, 14(1), 14052.
  • Surgical management of severe planovalgus foot deformity in children with generalised joint hypermobility
    • Authors: Alhassan, M.S., Park, B.K., Shah, M., Rhee, I., Kim, H.W.
    • Year: 2024
    • Citation: Foot and Ankle Surgery.
  • Concomitant talocalcaneal coalition as a risk factor for early relapse following Ponseti treatment of idiopathic clubfoot
    • Authors: Shah, M., Rhee, I., Lee, S.K., Alhassan, M.S., Kim, H.W.
    • Year: 2021
    • Citation: Diagnostics, 11(9), 1682.

Xian Wei | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Xian Wei | Medicine and Dentistry | Best Researcher Award

Plastic Surgeon at Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, China

Dr. Xian Wei is a distinguished plastic surgeon at the Department of Plastic and Reconstructive Surgery at Shanghai Ninth People’s Hospital, affiliated with Shanghai Jiaotong University School of Medicine. With a robust educational background, including a seven-year training program at NTU Medical College and an M.D., Ph.D. from Shanghai Second Medical University, he has dedicated his career to advancing surgical practices. His postdoctoral work focused on transsexualism, emphasizing his commitment to innovative healthcare solutions. Dr. Wei is known for his contributions to the field, particularly in patient safety and reconstructive techniques, making him a prominent figure in plastic surgery. 🏥✂️

Professional Profile:

Education🎓 

Dr. Wei’s educational journey began with a seven-year training program at NTU Medical College from 1994 to 2001, where he developed foundational medical knowledge. He continued his studies at Shanghai Second Medical University, earning his M.D. and Ph.D. between 2002 and 2005. Following his doctoral studies, he pursued postdoctoral research at the Second Military Medical University, specializing in transsexualism from 2012 to 2015. His academic achievements reflect a deep commitment to understanding the complexities of surgery and patient care. Through extensive training and research, Dr. Wei has honed his skills in plastic surgery, preparing him to tackle challenging cases with expertise and compassion. 📚🔬

Professional Experience 💼

Dr. Xian Wei currently serves as a plastic surgeon at the Shanghai Ninth People’s Hospital, where he has been practicing since completing his education. His clinical responsibilities encompass a wide range of procedures, focusing on reconstructive and aesthetic surgeries. He has published several influential papers, addressing critical issues in plastic surgery, including patient safety and innovative surgical techniques. His work not only enhances surgical outcomes but also prioritizes patient protection and ethical considerations in healthcare. Dr. Wei’s vast experience in the field enables him to train and mentor the next generation of surgeons, fostering a culture of excellence in plastic and reconstructive surgery. 👨‍⚕️💼

Research Interest🔍

Dr. Wei’s research interests lie primarily in plastic and reconstructive surgery, with a specific focus on the care and treatment of transgender patients. He has explored various aspects of surgical techniques, including the customization of soft tissue expanders and the implications of perioperative risks in vascularized composite allotransplantation. His work aims to improve patient safety, enhance surgical outcomes, and advocate for better protections for transgender individuals in healthcare settings. Dr. Wei is committed to pushing the boundaries of plastic surgery through innovative research, ensuring that patients receive the highest standard of care. 💡🔬

Awards and Honors

Dr. Xian Wei has been recognized for his significant contributions to the field of plastic surgery, particularly through his publications in esteemed journals. His work has received accolades for addressing critical issues such as organ transplantation and patient rights, highlighting his advocacy for marginalized groups. While specific awards are not listed, his influence in the medical community is evident through his research impact and his role in advancing surgical techniques. His commitment to excellence and innovation has positioned him as a respected leader in plastic surgery, paving the way for future advancements in the field. 🥇📜

Publications top noted📜
  1. Transgender patients need better protection in China
    Authors: Jiang, H., Wei, X., Zhu, X., Wang, H., Li, Q.
    Year: 2014
    Citation: The Lancet, 384(9960), pp. 2109–2110
    Citations: 19 🌈
  2. Organ transplantation in China – Not yet a new era
    Authors: Wei, X., Jiang, H., Li, Q.
    Year: 2014
    Citation: The Lancet, 384(9945), pp. 741
    Citations: 5 🏥